“SkyQuest Technology Group has recently published a comprehensive Molecular Diagnostics Market report, offering a detailed analysis of the product landscape and industry scope while providing insights into the market outlook and future trends from 2025 to 2032. This study segments the market across major regions, each contributing to the growing momentum of market development. The Molecular Diagnostics Market is growing strong, fueled by a boost in demand for precision medicine and early disease identification. Among the most important drivers is the rising incidence of infectious diseases and cancers worldwide, which calls for swift and accurate diagnostic technologies.
Global Molecular Diagnostics Market size was valued at USD 15.8 billion in 2023 and is poised to grow from USD 16.89 billion in 2024 to USD 28.8 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).
Technological advances—real-time PCR, next-generation sequencing (NGS), and microarray methods—are making for speedier, more accurate identification of pathogens and genetic mutations. Also contributing to the expansion of the market is the increased use of companion diagnostics to direct targeted treatments in oncology and other chronic diseases. The increasing use of molecular diagnostics in daily clinical practice, particularly in developed markets, is also augmenting the growth of the market. Another force driving the market is the increasing trend of point-of-care (POC) testing and at-home diagnostics, fueled by the COVID-19 pandemic.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/molecular-diagnostics-market
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Molecular Diagnostics Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Global Molecular Diagnostics Market is segmented by Product, Test Type, Sample Type, Technology, Application, End User and region.
Based on Product, the market is segmented into Reagents & Kits, Instruments and Services & Software.
Based on Test Type, the market is segmented into Lab Tests and POC Tests.
Based on Sample Type, the market is segmented into Blood, Serum, And Plasma, Urine and Other Sample Types.
Based on Technology, the market is segmented into Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, In Situ Hybridization, DNA Microarrays and Other Technologies.
Based on Application, the market is segmented into Infectious Disease Diagnostics, Oncology Testing, Genetic Testing and Other Applications.
Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics and Other End Users.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Molecular Diagnostics Market – Regional Analysis:
North America is the largest contributor to the molecular diagnostics market, capturing about 40.9% of the world’s revenue. The U.S. is leading this region due to its strong healthcare infrastructure, high uptake of advanced diagnostic technologies, and huge investments in research and development.
United States dominates the molecular diagnostics market with around 87% of the local share. The country’s dominance can be explained by a strong healthcare infrastructure, high level of adoption of cutting-edge diagnostic technologies, and presence of leading market participants.
Canada is an emerging market in the molecular diagnostics space, which is expected to expand at around 5% CAGR during 2024-2029. The rising emphasis on preventive care and early detection of diseases by Canada’s healthcare system has been one of the major drivers of growth. One of the recent developments includes the acquisition of Canada’s LifeLabs by Quest Diagnostics at around C$1.35 billion to strengthen its foothold in the Canadian market.
Europe is witnessing tremendous growth in the molecular diagnostics market, with nations such as Germany and France leading the way. Germany, for example, invests more than €5 billion each year on cancer research, fueling demand for oncology-specific molecular tests. Molecular diagnostics are now utilized in 80% of cancer treatment pathways in the nation.
Top Market Players in Molecular Diagnostics Market are:
F. Hoffmann-La Roche Ltd. (Switzerland)
Hologic, Inc. (US)
Abbott Laboratories (US)
Illumina, Inc. (US)
Thermo Fisher Scientific Inc. (US)
bioMerieux (France)
QIAGEN (Netherlands)
Becton Dickinson And Company (US)
Grifols S.A. (Spain)
Bio-Rad Laboratories, Inc. (US)
Sysmex Corporation (Japan)
Quidel Corporation (US)
Biocartis (Belgium)
DiaSorin (Italy)
Myriad Genetics (US)
Revvity (US)
MDxHealth (Belgium)
OncoCyte Corporation (US)
Molecular Diagnostics Key Market Trends:
Shift towards Point-of-Care Testing
There is a growing trend towards point-of-care molecular testing, driven by the need for rapid diagnosis and treatment monitoring in various healthcare settings, including clinics, emergency rooms, and ambulances. Miniaturized and portable molecular diagnostic devices are being developed to enable real-time testing outside traditional laboratory settings, enhancing patient care and healthcare efficiency.
Integration of Artificial Intelligence (AI) and Big Data Analytics
The integration of AI and big data analytics in molecular diagnostics is revolutionizing data interpretation, enabling more accurate and personalized diagnosis and treatment strategies. Machine learning algorithms can analyze vast amounts of genomic data to identify disease patterns, predict treatment responses, and optimize therapeutic outcomes. This trend is expected to accelerate the adoption of molecular diagnostics in precision medicine and improve patient outcomes.
You may Also Like
https://www.skyquestt.com/report/mens-wear-market
https://issuu.com/skyquest-technology/docs/smart_furniture_market_revenue_dynamics_and_key_mi
Forward-Looking Insights
The Molecular Diagnostics Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]”
